QuestionSBA
QuestionChoice
Carbidopa is given along with levodopa for symptomatic relief in Parkinson's disease. It reduces the conversion of L-dopa to dopamine in the periphery and prevent side effects. This increases the central effect of dopamine and reduces symptoms.
10003086
a
Peripheral dopamine decarboxylase inhibitor
QuestionChoice
These are drugs like rasagiline and selegiline. These reduce breakdown of dopamine in the CNS and reduce symptoms of Parkinson's.
10003089
d
Monoamine oxidase inhibitor
QuestionChoice
These are drugs like tolcapone, entacapone. These reduce breakdown of dopamine in the CNS and reduce symptoms of Parkinson's.
10003090
e
COMT inhibitors
QuestionChoice
This is levodopa. This is converted to dopamine in the CNS and reduces symptoms of Parkinson's.
10003088
c
Dopamine precursor
QuestionChoice
These are drugs like retigabine and pramipexole. These stimulate the central nervous syndrome and reduce symptoms in Parkinson's.
10003087
b
Dopamine agonist
Concept
Chapter
2693
4113
Parkinson's Disease
Topic
191
Geriatrics
13164
A 82 year is on levodopa and carbidopa for Parkinson's disease.

What is the mechanism of action of carbidopa?
a